ACHE and anxiety disorder: Moreover, it has been demonstrated that 60–90% of AD patients develop neuropsychiatric symptoms including anxiety disorder that could be treated with acetylcholinesterase inhibitors (AChEIs) (Cummings et al., 2016; Botto et al., 2022).